Chief Medical Officer
Rockwell Medical, Inc.
Dr. Hoffman has extensive experience in global drug development, medical affairs, pharmacovigilance and regulatory affairs, and has a proven track record in building, managing and globalizing medical teams for pharmaceutical companies; through both in-house roles at companies such as Baxter and Hospira and in senior leadership positions at various global contract research organizations (CROs), including Covance and, Parexel. Dr. Hoffman served as Chief Medical Officer at Celerion, Inc, a leader in early phase development and Patient iP. Dr. Hoffman has also held the roles of Chief Medical Officer and Senior Vice President & General Manager over the Biopharmaceutical Business Unit at Theorem Clinical Research.
Dr Hoffman received his bachelor’s degree in psychology from Emory University and his MD from American University of the Caribbean. He completed the Diploma in Pharmaceutical Medicine organized jointly by BrAPP (British Association of Pharmaceutical Physicians) and Cardiff School of Pharmacy and Pharmaceutical Sciences, Cardiff University.
Rockwell Medical (Employment, Ownership Interest includes stock, stock options, patent or other intellectual property)
Monday, March 14, 2022
1:30pm – 3:00pm CT
